order to produce and market medicines that benefit
is conducting research and development in conjunction
with universities and researchers all over the world in
order to seek out and patent technologies and the seeds
of new development. Based on those patents, we are able
to activate a broad international network of
researchers, pressing forward with work on preclinical
trials and clinical development.
core technology consists of the application of liposome
to DDS for the purposes of developing new drugs. We are
working day and night to bring our anticancer liposome
technology to actual medical treatment as soon and
effectively as possible.
and development with the world market in mind
research and development department at Mebiopharm
conducts research into new medicines with a view to
bringing our medicines to actual medical practice as
soon as possible. By optimizing the networks of our U.S.
branch office, numerous partnerships with companies in
Canada, Europe and elsewhere, as well as our
partnerships with researchers, we are always moving
forward with research centering on clinical development.